AWA
RLAY icon

Arkadios Wealth Advisors’s Relay Therapeutics RLAY Stock Holding History

Arkadios Wealth Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,635
Closed -$88.7K – 1509
2025
Q2 		$88.7K Sell
25,635
-34
-0.1% -$101 ﹤0.01% 1261
2025
Q1 		$67.3K Buy
+25,669
New +$101K ﹤0.01% 1091

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Arkadios Wealth Advisors's RLAY Position: Q3 2025 in Review

Arkadios Wealth Advisors sold out of Relay Therapeutics (RLAY) in Q3 2025, closing a stake of 25,635 shares — an estimated $88.7K sold.

Arkadios Wealth Advisors first reported a position in RLAY in Q1 2025 and held it in 2 quarters. The position peaked at $88.7K in Q2 2025. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • Arkadios Wealth Advisors reported no remaining Relay Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 25,635 Relay Therapeutics shares in Q3 2025, an estimated $88.7K.
  • Arkadios Wealth Advisors first reported a position in Relay Therapeutics in Q1 2025 and held it in 2 quarters.
  • Arkadios Wealth Advisors's Relay Therapeutics position peaked at $88.7K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2025, filed 29 Oct 2025.